Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Tuesday, as follows:
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) was started as Buy with a 60 target price at Guggenheim.
Adobe Inc. (NASDAQ:ADBE) was reiterated as Buy and its target price was raised to 368 at Argus.
Boston Scientific Corp. (NYSE:BSX) was reiterated as Overweight and its target price was raised to 52 at Wells Fargo.
Goldman Sachs Group Inc. (NYSE:GS) was raised to Buy from Neutral with a 255 target price at Citigroup.
Intercontinental Exchange Inc. (NYSE:ICE) was started as Outperform at Credit Suisse.
Nasdaq Inc. (NASDAQ:NDAQ) was started as Outperform at Credit Suisse.
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) was reiterated as Buy and the target price was raised to 248 at Argus.
Latest posts by HEFFX (see all)
- Tesla Is Hiring Someone To Defend Elon Musk And Fend Off Attacks By Twitter Trolls - January 20, 2021
- PayPal Will Continue To Profit From A Huge Increase In Volume And Accounts - January 20, 2021
- Google’s Ethical AI Division Investigating Sharing of Sensitive Documents - January 20, 2021